Vessel Sealing Devices Market Size & Share 2025 – 2034

Vessel Sealing Devices Market Size

The global vessel sealing devices market was valued at USD 3 billion in 2024 and is expected to exhibit growth at a CAGR of 6% from 2025 to 2034. The raising prevalence of chronic diseases along with the increasing ribose demand for minimally invasive surgery contributes to the high market growth.

With the increasing prevalence of cancer, processes for tumor removal and its treatments are also likely to increase. World Health Organization (WHO) indicates that in 2020 there were about 19.3 million new cancer cases worldwide. In the category of diagnostic and therapeutic oncology, a vessel sealing device is an important component because it guarantees a reliable seal of blood vessels, thus reducing intraoperative blood loss and improving patient care.
 

Besides, people with chronic diseases hardly get invasive surgeries that increase the time needed for recovery and complications. The use of vessel sealing devices is becoming more frequent in laparoscopic and robotic-assisted surgery in order to manage complications associated with chronic diseases.
 

Vessel sealing devices are sophisticated surgical instruments used to seal off blood vessels, lymph vessels, and tissue bundles during surgery through minimally invasive techniques. These devices apply pressure combined with an energy source, which may be bipolar or ultrasound energy, to cause permanent fusion of the walls of the vessel and other connective tissues.
 

Vessel Sealing Devices Market Trends

There have been major advances in inter device design, energy supply systems and incorporation to surgery platforms to enhance the work done by the tools and facilitate faster adoption.
 

• The cutting-edge devices employed for modern vessel sealing utilize energy sources like bipolar radiofrequency and ultrasonic technologies which achieves better hemostasis. This technology affords for controlled energy delivery which means less thermal spread to the tissues adjacent to the area of concern and the chances of complications arising during the surgery are lowered.
   
• Furthermore, there has been an increased shift toward the adoption of laparoscopic and robotic-assisted surgeries which in turn has fostered the invention and development of vessel-sealing devices that connect to these platforms. These devices, owing to their compact and ergonomic design coupled enhanced adjustment and accuracy, have become crucial and a necessity in minimally invasive procedures.
   
• The single-used vessel sealing devices have provided a solution to cross-contamination and infection control issues and concerns. In addition to that, hybrid devices that are working and used for contacting and sealing blood vessels have enhanced surgical workflows eliminating the need for a plethora of instruments.
   

Vessel Sealing Devices Market Analysis

Based on product, the market is classified into instruments, generators, and accessories. The instruments segment generated the highest revenue of USD 1.5 billion in 2024.
 

• These instruments have made their way into general, laparoscopic and robotic surgery which renders them useful in various applications and practices. Their multifunctionality especially in gynecological surgeries, colorectal surgeries and oncological practice only adds to their increasing share in the market.
   
• The segment of aids has been able to learn from continuous improvements such as ergonomic improvements, better articulation and better sealing, making it easier to control the energy served and for the surgeon to maintain lower levels of fatigue, improving the results of the surgery.
   

Based on technology, the vessel sealing devices market is classified into bipolar, ultrasonic, monopolar, and hybrid. The bipolar segment accounted for USD 1.3 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 5.3% between the 2025 – 2034 period.
 

• Bipolar vessel sealing devices work by applying energy through two electrodes which provides a very accurate control on the amount of heat and energy that needs to be provided. This type of operation reduces the chances of excessive heat being transferred to the tissues around the area reducing the chances of collateral damage.
   
• On top of that the generality of operation of bipolar devices allows the use of them in many types of surgical procedures which include general surgery, gynecology, urology and oncology. Their ability to seal both large vessels and small vessels effectively is one of the main reasons why they can be used in many areas of medicine.
   

Based on application, the vessel sealing devices market is classified into laparoscopic surgery and general surgery. The laparoscopic surgery segment generated the highest revenue of USD 1.9 billion in 2024.
 

• Less invasive laparoscopic surgeries have nowadays become the norm for most medical operations. These include cholecystectomy, appendicectomy and bariatric surgery. The fact that the required small recovery time and small cuts, played a large role in growing the segmental growth.
   
• Hysterectomies and myomectomies performed by gynecological specialists and oncologists during surgeries such as colectomies and prostatectomies are often accompanied with vessel sealing devices. The rise in applications of vessel sealing devices in this area has been associated with the inability to vessel seal during the particular surgeries in disadvantageous circumstances. Therefore, an increase in the demand for the devices may also be expected as a result.
   

Based on end use, the vessel sealing devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and other end use. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 2.2 billion by the end of the forecast period.
 

• General, gynecological, urological, and oncological surgeries are being performed in hospitals and these are high volume which means there is an increasing demand for vessel sealing devices. All these kinds of surgeries require vessel sealing and so there is an assured constant sale for vessel sealing devices.
   
• The operating theaters and surgical vessels of other types in the hospitals operate with props that have the latest technology for performing surgical procedures including sealing vessels. Being absorbed in the intricate details of the structure of the modern surgical workflow these devices are integrated into hospitals yielding the highest volume of consumption of these solutions in this particular market.
   

North America vessel sealing devices market accounted for USD 1.3 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 5.4% between the 2025 – 2034 period.
 

• The region has a high rate of chronic diseases in which surgical operations are needed for instance, oncological and cardiovascular diseases, which originate from highly developed hospitals in the area.
   
• Furthermore, continuous product development by major industry players based in this region, Medtronic and Johnson & Johnson, on minimally invasive surgical operations complements North America’s dominance in this market.
   

France vessel sealing devices market is projected to grow remarkably in the coming years.
 

• Since the nation has a growing need for vessel sealing tools that enable them perform minimally invasive surgeries especially in the field of gynecology and general surgery, these tools have been embraced.
   
• The initiatives undertaken by the government with respect to the improvement of existing healthcare infrastructure and surgical training programs are also significant contributors to the market development.
   
• More so, the availability of trained surgeons and the prevalence of laparoscopic surgery in France further boosts the country’s solid market foundation.
   

Japan holds a dominant position in the Asia Pacific vessel sealing devices market.
 

• Since the Japanese population is blessed with a technological aware and quick deploying healthcare system, the use of energy based surgical tools such as vessel sealing devices are already being widely used. Japan has a preference of minimally invasive procedures which blends well with the rising consumer need of high degree of safety and precision in the surgical procedures.
   
• In addition, the cooperation between foreign companies and local businesses promotes the introduction of innovations and provision of state-of-the-art goods designed for the healthcare providers of Japan.
   

Vessel Sealing Devices Market Share

The competition in the vessel sealing device market is characterized by the presence of major innovation leaders such as multinational companies including B. Braun, Johnson & Johnson and Medtronic which have large product ranges. Regional firms and newcomers from APAC region are also slowly developing. There are regular advancements in the techniques which include new energy developments, incorporation into platforms for minimally invasive surgery, greater sealing efficacy and many others. Companies are involved in strategic partnerships, mergers and acquisitions in order to widen geographical area of operations and improve technology.
 

Vessel Sealing Devices Market Companies

Prominent players operating in the vessel sealing devices industry include:

• B. Braun
• Bolder Surgical
• BOWA Medical
• CONMED Corporation
• Erbe Elektromedizin
• Intuitive Surgical
• Johnson & Johnson
• KLS Martin Group
• Medtronic plc
• Micromed
• Olympus Corporation
• OmniGuide Holdings
   

USPs for Key Players:

• B. Braun: Offers precision-engineered vessel sealing systems with advanced energy-based technology for optimal hemostasis and reduced thermal spread.
   
• Johnson & Johnson: Through Ethicon, provides innovative vessel sealing solutions with adaptive tissue technology, ensuring consistent and secure sealing across various surgical applications.
   
• Olympus Corporation: Specializes in high-performance vessel sealing devices integrated with cutting-edge laparoscopic and electrosurgical systems for enhanced procedural efficiency.
   

Vessel Sealing Devices Industry News: 

• In June 2021, Ethicon, part of Johnson & Johnson announced the launch of the ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency and provided stronger sealing and better access to more tissue than LigaSure Maryland. This product launch helped the company  enhance its business revenue.
   

The vessel sealing devices market research report includes in-depth coverage of the industry with estimates AND forecasts in terms of revenue in USD Million and volume in Units from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Instruments
• Generators
• Accessories

Market, By Technology

• Bipolar
• Ultrasonic
• Monopolar
• Hybrid

Market, By Application

• Laparoscopic surgery
• General surgery

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE